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Hyaluronan (HA) is widely used in the treatment of osteoartritis 
(OA) while its mechanisms of action is poorly understood. Since 
chondrocyte apoptosis seems involved in the pathogenesis of OA 
we investigated the in vitro effect of a 500-730 kd fraction of ther- 
apeutic hyaluronan (HA) on anti-Fas induced apoptosis of chon- 
drocytes from OA patients and its mechanism of action analyzing 
the role of the two HA receptors, CD44 and CD54 (ICAM-1). 
Methods: Chondrocytes isolated from human OA knee were cul- 
tured and the effect of HA was evaluated both on spontaneous 
and anti-Fas induced apoptosis. Apoptosis was analyzed by JAM 
test (for quantitative analysis of fragmented DNA), cell death 
detection immunoassay (for quantitative analysis of oligonucleo- 
some), TUNEL assay and electron microscopy. Blocking experi- 
ments with anti-CD44 and anti-CD54 alone or in combination 
were performed to investigate the HA action mechanism. 
Results: Both quantitative tests demonstrated that anti-Fas sig- 
nificantly induced apoptosis of isolated OA chondrocytes. HA at 
1000 mg/ml significantly reduced anti-Fas induced apoptosis of 
chondrocytes, but did not affect spontaneous chondrocyte apop- 
tosis. These data were also confirmed by TUNEL staining and by 
electron microscopy. Anti-apoptotic effects of HA on antiFAS 
induced chondrocyte apoptosis were significantly decreased by 
both anti-CD44 (67 ± 14% of inhibition) and CD54 (39 ± 30% of 
inhibition). The mixture of the two antibodies had an addictive 
effect, since the rate of inhibition increased to 87 ± 13%. 
Conclusions: The anti-apoptotic effect of HA mediated by its 
specific receptors can account for its therapeutic action in OA. 
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Endothelin- 1 (ET- 1) is known as a powerful vasoconstritor. This 
peptide is also found expressed in various tissues and cells and 
is suggested to play a role in many disorders including joint dis- 
eases. 
Method: This study was designed to determine the El-- 1 involve- 
ment in human osteoarthritis (OA) pathophysiology. To this end, 
we first evaluated its presence in cartilage and synovial mem- 
brane using immunohistochemistry, and further investigated 
whether ET-I possessed catabolic properties on cartilage. OA car- 
tilage was incubated in the absence or presence of increasing 
concentrations of ET-I, and the levels of metalloproteases (MMP), 
nitric oxide (NO), cyclooxygenase-2 (COX2) and apoptosis deter- 
mined. 
Results: Data showed that ET-1 is synthesized in both synovial 
membrane and cartilage. In cartilage, ET- 1 production was pref- 
erentially located in the superficial and upper intermediate layers 
of the tissue. The number of chondrocytes that specifically 
stained for ET- 1 in normal cartilage was very low (7.3+2.4%), and 
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significantly increased (28.1+8.8%, p<0.001)in OA. Moreover, in 
this pathological tissue, ET- 1 was immunocolocalized with the 
proinflammatory cytokine IL-II3. As in cartilage, ET-1 was also 
found at low levels in normal synovial membrane and dramatical- 
ly elevated in OA. In this tissue, ET-I specific immunostaining was 
found in the synovial lining cells as well as in the mononuclear 
cells. ET-1 demonstrated a selective effect on MMP production. It 
significantly stimulated MMP-I (control, 6.5±2.4; ET-I (10 nM), 
9.5+2.8 pg/100 mg tissue, p<0.O08) and MMP-13 (control, 
36.4±11.7; ET-1 (10 nM), 67.6±23.8 pg/100 mg tissue, p<0.007) 
but not MMP-3. This peptide also increased NO and COX-2 lev- 
els but had no effect on chondrocyte apoptosis. 
Conclusion: This study demonstrated, for the first time, the pres- 
ence of ET- 1 in human articular tissues with marked increase lev- 
els in OA cartilage and synovial membrane. We further demon- 
strated that ET-1 had a catabolic, but selective, role in OA carti- 
lage. Studies exploring the ET-1 metabolic pathways involved in
the cartilage catabolic processes are currently underway in our 
laboratory. 
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We recently showed that production of MMP-1 is under the con- 
trol of endogenously-produced arachidonic acid metabolites in 
human OA-affected synovial membranes. Our objective was to 
characterize the signaling pathways that mediate prostaglandin 
E 2 and J2 (PGE 2 and 15-deoxy-PGJ2) inhibition of basal and IL- 
113 activated collagenase-1 (MMP-1) gene expression in human 
OA-affected synovial membrane-derived synoviocytes (HSF). 
Interleukin-lb and phorbol ester (PMA) activated MMP-1 expres- 
sion and synthesis were both inhibited by PGE 2 (IC50 = 30± 5 
nmot/L) and 15-deoxy-PGJ 2 (IC50 4.5 ± 0.9 pmol/L) in a dose- 
dependent fashion as judged by Northern (mRNA) and EL1SA 
(protein) analysis. NS-398, a preferential COX-2 inhibitor, stimu- 
lated basal and PMA/IL-I~ induced MMP-1 expression. IL- 
l 13/PMA induction of MMP-1 promoter activity in HSF is depend- 
ent, in part, on the proximal (-66 bp) AP-I activation as judged by 
transient transfection analysis using wild-type and mutant pro- 
moter constructs in HSE PGE 2 stimulated while 15-deoxy-PGJ 2 
inhibited IL-113/PMA induction of AP-1 dependent MMP-1 pro- 
moter activity in HSE Northern and gel-shift analysis of potential 
AP-1 dimers revealed that IL-I~/PMA stimulated the transient 
expression of c-jun, junD, and c-fos expression while PGE 2 acti- 
vated the expression of c-los, fosB, ]unD and junD but strongly 
inhibited c-jun expression either alone or in the presence of IL- 
l 13/PMA. 15 deoxy PGJ 2 potently inhibited c-fos, c-jun, and lunD. 
Gel shift analysis detected MMP-1-AP-1 response element bind- 
ing in control and IL-113/PMA-induced cells which was inhibited 
by 15 deoxy PGJ 2 but not PGE 2. PGE 2 inhibited c/EBP-depend- 
ent activation of the MMP-1 promoter in a specific time frame that 
coincided with an increase in ERKI/2 and SAPK2A/p38ct signal- 
ing pathways; the effect of PGE 2 depended on an intact distal 
c/EBP site in the human MMP-I promoter. Both prostanoids have 
no effect of MMP-1 mRNA half-life. 
We conclude that 15 deoxy PGJ 2 inhibits cytokine-induced 
MMP-1 gene expression by blocking the synthesis of transcrip- 
tionally active AP-1 complexes while PGE 2 functions at a distal 
c/EBP enhancer site by blocking basal and IL-II3 induced c/EBP. 
This study describes a new auto-regulatory signaling paradigm in 
which membrane phospholipid-derived eicosanoids control 
cytokine target genes. 
